An alternative to traditional screening methods, the LungFusion panel identifies expressed translocations of known clinical relevance in formalin-fixed, paraffin-embedded and fresh frozen tissue samples.
Read MoreThe Association for Molecular Pathology has released a micro-costing analysis tool to aid in calculating the cost of next-generation sequencing (NGS) assays.
Read More
In development since the mid-1970s, next-generation sequencing has the ability to transform the focus of cancer diagnosis and treatment to a molecular basis.
Read More
A number of drivers are changing the pathology and laboratory medicine landscape, including workforce shortages and technology advances such as digital microscopy.
Read More
Notable breakthroughs in personalized medicine continue, but reimbursement hurdles and regulation concerns have posed occasional setbacks.
Read More